Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDE4A | P27815 | 1/20 | 0.32 |
| ▸ | PDE4B | Q07343 | 1/20 | 0.32 |
| ▸ | PDE4C | Q08493 | 1/20 | 0.32 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.32 |
| ▸ | LIMK1 | P53667 | 1/20 | 0.32 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.32 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.32 |
| ▸ | PIK3CB | P42338 | 1/20 | 0.32 |
| ▸ | PIK3CG | P48736 | 1/20 | 0.32 |
| ▸ | PRKCI | P41743 | 6/20 | 0.31 |
| ▸ | DHODH | Q02127 | 1/20 | 0.31 |
| ▸ | NPC1 | O15118 | 1/20 | 0.31 |
| ▸ | RAB9A | P51151 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.31 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20328434 | 0.89 | LIMK1 (0.34) | PDE4APDE4BPDE4CPDE4DLIMK1 | |
| SCHEMBL20328448 | 0.86 | ADORA2A (0.41) | PDE4APDE4BPDE4CPDE4DDHODH | |
| SCHEMBL21361045 | 0.84 | — | — | |
| SCHEMBL20328447 | 0.83 | MEN1 (0.42) | DHODHNPSR1 | |
| SCHEMBL20328433 | 0.78 | ADORA2A (0.37) | PDE4APDE4BPDE4CPDE4DLIMK1 | |
| SCHEMBL20328432 | 0.78 | ADORA2A (0.37) | PDE4APDE4BPDE4CPDE4DLIMK1 | |
| SCHEMBL23556014 | 0.77 | CYP1A1 (0.36) | — | |
| SCHEMBL23556010 | 0.77 | CYP1A1 (0.36) | — | |
| SCHEMBL20328475 | 0.77 | CYP11B1 (0.38) | PDE4APDE4BPDE4CPDE4DLIMK1 | |
| SCHEMBL20328438 | 0.76 | PDE4A (0.38) | PDE4APDE4BPDE4CPDE4DLIMK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10418567-B2 | Organic compound for organic EL device and using the same | LUMINESCENCE TECHNOLOGY CORP. (TW) | 2019-09-17 | — | — | US | disclosed |
| US-20180182978-A1 | ORGANIC COMPOUND FOR ORGANIC EL DEVICE AND USING THE SAME | LUMINESCENCE TECHNOLOGY CORPORATION (TW) | 2018-06-28 | — | — | US | disclosed |
| US-20180182978-A1 | ORGANIC COMPOUND FOR ORGANIC EL DEVICE AND USING THE SAME | LUMINESCENCE TECHNOLOGY CORPORATION (TW) | 2018-06-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10418567-B2 | Organic compound for organic EL device and using the same | EML4, LEF1, ELOB | PDE4A 4844/4885PDE4B 4775/4885PDE4C 4843/4885 |
| US-20180182978-A1 | ORGANIC COMPOUND FOR ORGANIC EL DEVICE AND USING THE SAME | EML4, LEF1, ELOB | PDE4A 4844/4885PDE4B 4775/4885PDE4C 4843/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.